After Hours Summary: LPCN +38% on positive trial results... RS -7% and CMG -2% following guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to news: LPCN +38.1% (announces LPCN 1021 achieved primary endpoints confirming the efficacy of twice daily oral administration andgenerally met the pre-specified per dose secondary endpoints for twice daily oral administration), ENPH +14.4% (Enphase Energy enters into a Master License Agreement with Flextronics Industrial), BLCM +6%, DDD +2.1%, CFMS +0.9% (continued strength), EYEG +3.9% (indicated higher after Armistice Capital discloses 9.9% passive stake), ALXN +1.6% (CEO disclosed the purchase of 10K shares at avg price of $116.72/share), TSLA +1.3% (reports nearing deal for China production plant), MU +0.6% (after seeing afternoon strength)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: RS -6.6% (light volume), CMG -2.2%, (reaffirms/clarifies guidance for certain financial and operating results for Q2/FY17),
Companies trading lower in after hours in reaction to news: NEOS -7.3% (continued weakness), AVXS -4.3% (to offer up to $200 million of shares of its common stock in an underwritten public offering), FDUS -2.6% (commences public offering of 1.5 mln shares of its common stock), CLVS -1.7% (commences underwritten public offering of shares of its common stock to raise aggregate proceeds of ~$250 mln), TDOC -0.8% (confirms definitive agreement to acquire Best Doctors; Teladoc reiterates its previously communicated second quarter 2017)